Drug resistance in newly discovered untreated tuberculosis patients in Poland, 1974–1977

In a six-year survey 10(0.15%) of 6849 patients with European names and 31 (1.0%) of 3079 patients with non-European names yielded cultures of Mycobacteriumn tuberculosis that were resistant to rifampicin. Only two of each group had organisms resistant to rifampicin alone. Resistance to one or more other antituberculous drugs was found in eight of the European and 29 of the non-European group. Two patients in each group were known to have received treatment for the first time in the United Kingdom; 17 of the non-Europeans were known to have been treated abroad; precise information was not available for the other 12. The overall six-year incidence of patients with rifampicin-resistant M tuberculosis was only 0.41%. The very low incidence among Europeans is probably the result of stricter regimens than are possible in some other areas.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Drug resistance in newly discovered untreated tuberculosis patients in Poland, 1974–1977

Cited by 3 publications

References 6 publications

Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India

Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India

Multidrug-resistant Tuberculosis

Low incidence of rifampicin-resistant tubercle bacilli.

Contact Info

Product

Resources

About